• What We Do

    Building a pipeline of unique assets enabled by a world-leading platform for antibody discovery


    An unparalleled platform for the targeting GPCRs with antibodies

    HEPTAD is DJS Antibodies' proprietary antibody discovery technology and delivers unprecedented success rates in the discovery of functional antibodies to GPCRs. It is built on a deep understanding of immunology and antibody production enabling us to discover functional antibodies to complex protein targets which have hitherto been intractable to drug discovery.

    Asset Development

    Creating value through the development of unique therapeutics

    We use HEPTAD to discover antibodies against challenging GPCR targets where there is a strong commercial case for an antibody therapeutic. Lead antibodies discovered with HEPTAD are fed into our antibody development pipeline where our expert team works to accelerate their development through preclinical milestones and into the clinic.

  • Pipeline

    We are building a unique pipeline of unique first-in-class antibody assets



    DJS-001 targets the tumour microenvironment to alleviate immunosuppression and enhance checkpoint inhibitor efficacy.


    Novel biological insight positions DJS to develop a world-leading IO therapeutic.

    Chronic Kidney Disease


    DJS-002 targets the key processes of fibrosis and filtration unit breakdown associated with CKD.


    DJS has produced the first ever functional antibodies shown to antagonise signalling through this GPCR.

  • Our Team

    Board of Directors

    David Llewellyn


    David completed a DPhil in Clinical Medicine at the University of Oxford as a Rhodes Scholar. He is an expert in the generation and characterisation of antibodies and has developed novel techniques for immune modulation.

    Joe Illingworth


    Joe has a background in biochemistry and immunology. He completed a DPhil and Post-doctoral work at the University of Oxford on antibody inducing vaccines. His expertise include inducing potent antibody responses to proteins which are difficult to express recombinantly.

    Graeme Martin


    Graeme has a background in pharmaceutical R&D with Glaxo Wellcome and Roche having seen multiple programmes through preclinical development and into the clinic. Most recently, he has led Takeda Ventures as CEO, and has been working with DJS for 3 years.

    Andrew McLean


    Andy is a Principal at Oxford Sciences Innovation (OSI); an investment company formed to turn Oxford’s world beating science in world changing companies. Prior to joining OSI Andy trained as a physician and consulted in the pharmaceutical & biotech practice at McKinsey.

  • Join our team

    If you're looking to be surrounded by fantastic people and join an exciting team working on the cutting edge of drug discovery, get in touch!

    DJS Antibodies Ltd Privacy Notice
    This Privacy Notice for DJS Antibodies Ltd sets out the categories of your personal data we collect, how we collect it, what we use it for and with whom we share it, in accordance with applicable data protection legislation, including the General Data Protection Regulation (GDPR).
    DJS Antibodies is committed to ensuring that your privacy is protected. Should we ask you to provide certain information by which you can be identified when using our website, then you can be assured that it will only be used under the terms of this Privacy Notice.
    DJS Antibodies may change this policy from time to time by updating this page. You should check this page from time to time to ensure that you are happy with any changes. This policy is effective from 1st January 2020.
    Should you have any questions about this Privacy Notice you can contact us by sending an email to david.llewellyn@djsantibodies.com or write to us at: 
    DJS Antibodies Ltd 
    Cherwell Innovation Centre
    77 Heyford Park
    Upper Heyford
    OX25 5HD 
    What we collect
    We may collect the following information:
    •	Personal identifiers (e.g. name and job description)
    •	Contact information including email address
    •	Demographic information such as postcode, preferences, and interests
    How we get the personal information and why we have it
    Most of the personal information we process is provided to us directly by you for one of the following reasons:
    •	Applications for and enquiries into employment opportunities
    •	Enquiries about DJS Antibodies, our operations and our R&D
    We use the information that you have given us in order to respond appropriately to enquiries, identify appropriate employment opportunities, maintain internal records, and inform you of updates that are relevant to your reason for supplying us with your personal data. 
    We may share your personal data with third parties where this is required by law, where it is necessary to perform our contract with you, or where we have another legitimate interest in doing so.
    Under the General Data Protection Regulation (GDPR), the lawful bases we rely on for processing this information are: 
    a)	We have a contractual obligation.
    b)	We have a legal obligation.
    c)	We have a legitimate interest.
    Where we store your personal data 
    All information you provide to us will be stored on our secure servers. Once we have received your information, we will use appropriate technical and organizational measures to prevent unauthorised access, disclosure, loss or damage to your personal data. 
    How long will we retain your information? 
    We will only retain your personal information for as long as necessary to fulfil the purposes for which it was collected, including for the purposes of satisfying any legal, regulatory, accounting or reporting requirements.
    Once we no longer require your personal data for the purposes for which it is processed, we will securely destroy your personal data in accordance with applicable laws and regulations and in accordance with our records retention policy.
    Your data protection rights
    Under data protection law, you have rights including:
    •	Your right of access - You have the right to ask us for copies of your personal information. 
    •	Your right to rectification - You have the right to ask us to rectify personal information you think is inaccurate. You also have the right to ask us to complete information you think is incomplete. 
    •	Your right to erasure - You have the right to ask us to erase your personal information in certain circumstances. 
    •	Your right to restriction of processing - You have the right to ask us to restrict the processing of your personal information in certain circumstances. 
    •	Your right to object to processing - You have the the right to object to the processing of your personal information in certain circumstances.
    •	Your right to data portability - You have the right to ask that we transfer the personal information you gave us to another organisation, or to you, in certain circumstances.
    You are not required to pay any charge for exercising your rights. If you make a request, we have one month to respond to you.
    If you wish to make a request, please contact us at: david.llewellyn@djsantibodies.com; or
    DJS Antibodies Ltd 
    Cherwell Innovation Centre
    77 Heyford Park
    Upper Heyford
    OX25 5HD 
    How to complain
    If you have any concerns about our use of your personal information, you can make a complaint to us at david.llewellyn@djsantibodies.com.
    You can also complain to the ICO if you are unhappy with how we have used your data.
    The ICO’s address:
    Information Commissioner’s Office
    Wycliffe House
    Water Lane
    SK9 5AF
    Helpline number: 0303 123 1113
    ICO website: https://www.ico.org.uk